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Abstract Surgical resections of large-to-giant pituitary
adenomas (PA) are technically challenging procedures.
Tumors with a ﬁbrous consistency or ‘hour-glass’ conﬁg-
urations are particularly difﬁcult to remove completely and
safely through the transsphenoidal route alone. Although
the transcranial approach can facilitate the removal of a
large suprasellar mass, it may be associated with signiﬁcant
bleeding within the intradural space. A simultaneous
microscopic transcranial and transsphenoidal approach has
been described as an alternative surgical strategy. We have
further modiﬁed this ‘above and below’ approach by
adopting endoscopic techniques for the transsphenoidal
part of the procedure. This modiﬁed approach has the
advantages of requiring only one operating microscope,
and permitting freer maneuvers and easier orientation for
both surgical teams. We present two patients successfully
treated with this approach. Complete tumor removal was
achieved and both patients achieved satisfactory functional
recovery.
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Introduction
Surgical resections of large-to-giant pituitary adenomas
(PAs) are technically challenging procedures. Tumors with
a ﬁbrous consistency or ‘hour-glass’ conﬁgurations are
particularly difﬁcult to remove completely and safely
through the transsphenoidal route alone. Although the
transcranial approach can facilitate the removal of a large
suprasellar mass, it may be associated with signiﬁcant
bleeding within the intradural space [1]. Other approaches
such as the staged transsphenoidal approach [2] and the
staged transcranial-transsphenoidal approach [3] are
potentially effective strategies but have the disadvantage of
requiring multiple operations.
An alternative technique of simultaneous ‘above and
below’ resection of large PAs has been described [3–5]. It
combines a microscopic transsphenoidal approach with a
craniotomy in a single setting. We have further modiﬁed
this approach by adopting endonasal endoscopic techniques
for the transsphenoidal part of the procedure. We present
here two patients treated with this technique and discuss its
applications and limitations.
Surgical procedure
The tumor was approached both transcranially and trans-
sphenoidally by two surgical teams under a single setting
of general anesthesia. The transsphenoidal surgeon stood
on the right side of the patient while the transcranial sur-
geon was seated at the head end (Fig. 1) . The transcranial
surgeon approached the tumor through a pterional crani-
otomy under the operating microscope. But unlike the
combined approach previously described [3, 4] our
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dard endonasal endoscopic techniques [6].
The tumor was ﬁrst exposed on the cranial side but
every effort was made to avoid breaching the tumor cap-
sule to minimize bleeding within the intradural space. The
cranial surgeon’s role was to dissect the tumor capsule
from adjacent structures, to protect the latter against the
transsphenoidal surgeon’s manipulations, and to deliver the
tumor towards the sphenoidal sinus. The tumor capsule was
ﬁrst opened on the transsphenoidal side, followed by tumor
debulking. The subsequent skull base defect was repaired
with abdominal fat graft. Again, the cranial surgeon served
to prevent against over-enthusiastic packing by the trans-
sphenoidal surgeon. Wound closure was performed in the
standard manner. A subgaleal suction drain was inserted on
the cranial side, and the nasal passages were packed for
1 day. No lumbar drain was used.
Illustrative case 1
A 61-year-old man presented with 2 months’ history of
blurring of vision. On examination, he had a left temporal
hemianopia. His visual acuity was 0.3 (right) and 0.1 (left).
Basal pituitary function evaluation revealed a serum pro-
lactin (PRL) level of 154 mU/l (normal values 70–417 mU/
l) and panhypopituitarism. There was no clinical evidence
of diabetes insipidus (DI). Hydrocortisone and thyroxine
replacement was commenced. Magnetic resonance imaging
(MRI) revealed a 3.8 9 4.2 9 4.5 cm (transverse (TR) 9
anterior-posterior (AP) 9 longitudinal (L)) sellar mass with
optic chiasmal compression and third ventricular extension.
The ﬁndings were compatible with a Hardy Grade II Stage
B lesion [7] (Fig. 2a, b). The patient underwent tumor
removal with the procedure described above. Pathological
examination conﬁrmed a non-functioning PA. His visual
acuity improved post-operatively to 0.4 (right) and 0.7 (left)
after surgery. The visual ﬁeld recovered except for a
residual rim of peripheral loss. He developed permanent DI
and required full pituitary hormone replacement therapy.
Post-operative MRI performed 3 months afterwards
showed no residual tumor (Fig. 2c, d)
Illustrative case 2
A 60-year-old man presented with 1 week’s history of
blurring of vision and headache. On examination, he had
signiﬁcant bitemporal hemianopia. Laboratory investiga-
tions revealed hyponatremia of 118 mmol/l (normal values
136–148 mmol/l). The random spot serum cortisol was less
than 22 nmol/l. The serum PRL level was 628 mU/l (nor-
mal values 70–417 mU/l). Other anterior pituitary hor-
mones levels were subnormal. There was no clinical
evidence of DI. MRI revealed a suprasellar tumor mea-
suring 3.8 9 4.2 9 4.5 cm (TR 9 AP 9 L) with hetero-
geneous contrast enhancement, optic chiasm compression
and third ventricular extension. The ﬁndings were com-
patible with a Hardy Grade III Stage B lesion [7] (Fig. 3a,
b). The patient was commenced on hydrocortisone and
thyroxine replacement, and underwent a gross total tumor
removal 1 week later. The pathology was a non-function-
ing PA, with focal immuno-staining positivity with TSH
and FSH/LH. The patient’s visual ﬁeld recovered com-
pletely. He developed permanent DI. MRI performed
9 months later demonstrated complete removal of the
tumor mass (Fig. 3c, d)
Discussion
Surgery is the treatment of choice for non-functioning
large-to-giant PAs. But complete tumor removal can be
difﬁcult to accomplish and the procedure may be associ-
ated with signiﬁcant morbidities or even mortalities. His-
torically, the operative mortality rates were as high as 14%
for transsphenoidal and 25% for transcranial resections [8].
More recent series have reported better outcomes [9–11].
In Mortini’s series of 111 patients with huge PA, the
treatment mortality rate was 2.7% [10]. Sinha et al. simi-
larly reported mortality and morbidity rates of 4.4 and
14%, respectively [9]. The introduction of endoscopic
pituitary surgery has further revolutionized the treatment of
these difﬁcult lesions [12, 13]. The extended endoscopic
transsphenoidal technique, in particular, has been shown to
facilitate the safe removal of large tumors which previously
were not amendable to complete resection through a single
Fig. 1 A schematic diagram illustrating the arrangement in the
operating theatre
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123route alone [14, 15]. However, considerable experiences
and technical expertise are needed before this technique
can be used to its full advantages [6].
One of the difﬁculties encountered during transsphe-
noidal resection of giant PAs is that the suprasellar tumor
portion may ‘refuse’ to descend into the sella. Several
techniques have been described to address this problem,
including the use of Valsalva’s maneuvers, intraspinal
saline infusion, and staged removals [2]. A simultaneous
‘above and below’ technique has been described which
combines a transsphenoidal approach with a craniotomy.
With this approach, Alleyne et al. achieved a gross total
resection rate of 40% in a cohort of 10 patients. More than
half of the patients who had pre-operative visual ﬁeld
defects experienced complete improvement. Permanent DI
occurred in 20% of patients [3]. In D’Ambrosio’s series,
gross total resection was achieved in six out of 11 patients.
Seven patients (64%) experienced visual improvement.
Panhypopituitarism occurred in four and persistent DI in
two patients [4]. The technique described by these two
groups required one operating microscope for each of the
transsphenoidal and transcranial teams. In our experience,
this may create difﬁculties with positioning as the two
microscopes tended to clash over the patient’s head.
Furthermore, not all centres can have two microscopes
readily available. The head rotation required for the pter-
ional craniotomy may also disorientate the transsphenoidal
surgeon who tried to approach the sella sublabially.
Our modiﬁed technique thus takes advantages of the
‘above and below’ approach as well as that of endoscopic
surgery. It requires only one operating microscope. It also
permits freer movement by both surgical teams since the
endoscope and the microscope occupy different air-spaces
above the patient’s body. The endonasal endoscopeic
method provides excellent visualization and illumination of
the operative ﬁeld, and is associated with minimal soft
tissue damage within the nose. The monitors of the
microscope and the endoscope can be positioned to allow
both teams to see each other’s operative ﬁelds. The trans-
cranial surgeon serves to deliver the tumor bulk and to
protect intradural structures. There is minimal tumor
bleeding within the subarachnoid space. Safe and complete
tumor removal can be achieved in selected cases.
The use of endoscopes for the simultaneous ‘above and
below’ approach has been described previously [16–18].
These authorities combined the use of endonasal with
transventricular endoscopes. The technique was particu-
larly suitable for tumors with third ventricular extension
Fig. 2 Contrasted T1-weighted
magnetic resonance images of
Patient Case 1. a Pre-operative
coronal; b pre-operative
sagittal; c post-operative
coronal; d post-operative
sagittal
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123and ventricular dilatation. Our modiﬁed approach, on the
other hand, is applicable also for PAs which are not causing
hydrocephalus but for which a combined approach is still
potentially useful. Zada et al. recently reviewed 250
transsphenoidal operations and identiﬁed 13 complex sellar
lesions which would have beneﬁted more from transcranial
attack instead. Based on these lesions, eight factors were
found to limit the extent or safety of transsphenoidal
resections. These included signiﬁcant suprasellar exten-
sion, lateral extension, retrosellar extension, brain invasion
with edema, ﬁrm tumor consistency, involvement or
vasospasm of the arteries of the circle of Willis, and
encasement of the optic apparatus or invasion of the optic
foramina [19]. It is our opinion that some of these lesions
may also beneﬁt from our ‘above and below’ approach.
The factors identiﬁed by Zada et al. may be used as relative
indications for an ‘above and below’ approach.
It must be emphasized, however, that the optimal treat-
ment of huge PAs requires a tailored approach based on
individual patients’ conditions and the surgeons’ experi-
ences and abilities. Our technique therefore represents only
one of the many available strategies; it may be considered
as a safe alternative when expertise in a single-route
endonasal endoscopic removal is unavailable. For a com-
plex lesion that obviously requires a transcranial attack, an
additional simultaneous transsphenoidal approach may be
considered when the sellar tumor component is large or
when signiﬁcant bleeding is anticipated.
It is regrettable that both of our patients developed
permanent DI after surgery which, given their large tumors,
may not have been preventable. It is reasonable to assume
that at least some of the vasopressinergic neurons would
have been destroyed prior to surgery despite the absence of
clinical DI. Cortisol insufﬁciency, present in both patients
pre-operatively, is known to lessen the degree of polyuria
in those with combined anterior and posterior pituitary
diseases by reducing renal perfusion and increasing
endogenous anti-diuretic hormone release [20]. Further
damage sustained intra-operatively (e.g. due to axonal
shock) may then lead to clinically apparent permanent DI.
Moreover, the administration of cortisol during the peri-
operative period would also lead to the rapid onset of
polyuria [21]. We speculate that both of these mechanisms
(i.e. cumulatively pituitary insult and correction of cortisol
insufﬁciency) played a part in the pathogenesis of DI in our
patients.
Conclusion
The simultaneous ‘above and below’ technique is a safe
and feasible approach for large-to-giant PAs. The adoption
Fig. 3 Contrasted T1-weighted
magnetic resonance images of
Patient Case 2. a Pre-operative
coronal; b pre-operative
sagittal; c post-operative
coronal; d post-operative
sagittal
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123of the endonasal endoscopic transsphenoidal method
obviates the need for two operating microscopes, permits
freer maneuvers and better orientation for both surgical
teams, and is associated with minimal soft tissue injury
within the nose. It may be considered as an alternative
surgical approach for a carefully selected group of patients.
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